Multinodular Goiter And Homoeopathic Management
Phase 3
- Conditions
- Health Condition 1: E042- Nontoxic multinodular goiter
- Registration Number
- CTRI/2021/02/030948
- Lead Sponsor
- DrNeelima Mundanattu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients from 18 to 65 years of age.
2.Patients with positive ultrasonography for evidence of MNG.
3.Patients with euthyroid, hypothyroid, and hyperthyroid states
Exclusion Criteria
1.Evidence of malignant change in Ultrasonography.
2.Patients with complications such as signs and symptoms of excessive mechanical obstruction & pressure effects on adjacent structures which is diagnosed by necessary investigations.
3.Patients with any diagnosed severe systemic illness like uncontrolled Diabetes mellitus, Malignant hypertension and other malignancies etc.
4.Immunocompromised patients.
5.Pregnant and lactating mothers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Analyze the changes in the size of thyroid gland during the course of treatment through ultrasonography.Timepoint: 12 months
- Secondary Outcome Measures
Name Time Method 1) Analyze the changes in the values of Thyroid Function Tests. <br/ ><br>2)Identify any other tissue changes through ultrasonography after administration of Homoeopathic medicines. <br/ ><br>3)Analyze the changes in neck circumference <br/ ><br>4) Analyze the change in symptomatology after administration of Homoeopathic medicines and find out the commonly indicated homoeopathic medicines which are effective in treatment of the Multinodular goiter. <br/ ><br>Timepoint: 12 months